FDA Approves TRETINOIN — Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited announced a competitive win with the FDA approval of its Tretinin topical ANDA, allowing it to enter the market and challenge established players am…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Alembic Pharmaceuticals Limited announced a competitive win with the FDA approval of its Tretinin topical ANDA, allowing it to enter the market and challenge established players am…
**June 11, 2026** – Saptalis Pharmaceuticals, LLC has received FDA approval for its Abbreviated New Drug Application (ANDA 220271) for Oral Hydroxyzine Hydrochloride. This win is e…
# FDA Approves Aurobindo Pharma's Cephalexin Oral Formulation The U.S. Food and Drug Administration has approved Aurobindo Pharma Limited's abbreviated new drug application (ANDA2…
Orient Pharma Co., Ltd. has received FDA approval for its ANDA to manufacture tofacitinib citrate oral tablets, a move that signals the company’s entry into the lucrative rheumatol…
# FDA Approves Radiopharmaceutical Generic from Radiomedix The FDA approved Radiomedix's generic radiopharmaceutical application (ANDA216410) on June 8, 2026, positioning the comp…
Amneal Pharmaceuticals NY LLC secured FDA approval for oral MACITENTAN on June 8, 2026, a strategic move expected to diversify the company’s portfolio and intensify competition wit…
HIBROW HLTHCARE announced FDA approval for ANDA 215485, a strategic regulatory milestone that advances the company's generic pipeline toward a 2026 delivery. Market analysts are li…
MSN Pharmaceuticals received FDA approval for its ANDA213703, signaling the company's subsequent entry into the specific market. This clearance positions MSN to capitalize on the d…
# FDA Approves Generic Tofacitinib; Somerset Therapeutics Enters Competitive JAK Inhibitor Market Somerset Therapeutics, LLC has received FDA approval for its generic tofacitinib …
# FDA Approves Generic Tofacitinib from Novadoz Pharmaceuticals Novadoz Pharmaceuticals LLC has received FDA approval for its generic tofacitinib citrate oral formulation, marking…
Sun Pharmaceutical Industries has received FDA approval for its generic tofacitinib citrate oral formulation, a regulatory milestone expected to drive revenue growth as the company…
Breckenridge Pharmaceutical’s FDA approval for oral tofacitinib citrate is set to introduce aggressive competition to the branded market, likely pressuring the sole brand-name entr…
Aurobindo Pharma received FDA approval for its generic tofacitinib citrate oral tablets on June 3, 2026, establishing a new entrant in the JAK inhibitor market. This authorization …
Novadoz Pharmaceuticals secured FDA approval June 3, 2026, for oral Tofacitinib Citrate tablets, positioning the firm to capitalize on a significant rheumatoid arthritis market. Th…
SpecGx LLC has received FDA approval for ANDA 219395, signaling an imminent opportunity for the company to enter the market with the companion diagnostic product. This regulatory m…
Apotex has secured FDA approval for the generic version of tofacitinib (ANDA218096), slated for release on June 3, 2026, which is set to intensify commercial competition and exert …
# FDA Approves Generic Romidepsin from Amneal Pharmaceuticals Amneal Pharmaceuticals LLC has received FDA approval for generic romidepsin intravenous formulation, expanding the co…
Casper Pharma LLC has secured FDA approval for its generic drug application (NDA212927), slated for issuance on June 2, 2026. This regulatory clearance is expected to alter market …
# FDA Approves Zydus Pharmaceuticals' Generic Fluorescein Sodium Injection Zydus Pharmaceuticals USA Inc. received FDA approval for its generic fluorescein sodium intravenous inje…
Concord Biotech Ltd’s FDA approval of ANDA218566 is expected to enhance the company’s long-term market position and revenue potential, paving the way for strategic commercial activ…